Almac & Merck to Present Adaptive Case Study at Upcoming Conference
The session will explore logistics of a novel trial design. Throughout the session, the speakers will discuss the impact of randomization algorithms on drug supply operations, the importance of interim reporting, and approaches for implementing automated drug supply management.
Val Higgins, Vice President of Clinical Project Services at Almac comments “We are delighted to present our efforts alongside Merck and share insights from our collaboration with the industry. We believe the benefits associated with adaptive trial design are significant and we are confident that the interactive nature of this session will allow for a great educational opportunity.”
About Almac
Almac Clinical Technologies is a division of Almac that specializes in interactive technology and service solutions to increase the quality and efficiency of the clinical trial process. Our solutions include Interactive Voice and Web Response Systems (IXRS™) for patient randomization, tracking and clinical supply management, iTrial EDC for electronic case report form data collection, electronic patient reported outcome data collection, and web drug reconciliation.
The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, diagnostic/genomic services, API manufacture, formulation development, clinical trial supply and technology (IVRS/EDC), to commercial-scale manufacture. Almac provides services to over 600 companies including all the world leaders in the pharmaceutical and biotech sectors. The company is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California.
Contact: Meghan Adams
T: (001) 267-685-4284